Effective systemic therapy for the treatment of stage III melanoma has emerged. Whether this influences treatment choice in stage III melanoma patients with in-transit metastases is the subject of this review.
Cornelis Verhoef, MD, PhD
Advertisement
Articles by Cornelis Verhoef, MD, PhD
Advertisement
Latest Updated Articles
Isolated Limb Perfusion for Stage III Melanoma: Does It Still Have a Role in the Present Era of Effective Systemic Therapy?Published: December 15th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves T-DXd Plus Pertuzumab in Metastatic HER2+ Breast Cancer
2
How Should a Patient With Multiple Myeloma Manage Talquetamab’s Toxicity?
3
QOL Improvement in Breast Cancer Noted With YES System
4
What is Cevostamab’s Mechanism of Action in Multiple Myeloma?
5
